Retroviruses are commonly associated with neurological disease in animals, for example, inflammatory encephalomyelopathies of sheep (visna virus),' horses (equine infectious anaemia virus), goats (caprine encephalitis/arthritis virus)2 and mice (murine leukaemia virus).3 The first retrovirus shown to be pathogenic in humans was discovered by Gallo's group4 who demonstrated that human lymphotrophic virus type-i (HTLV-1) was the cause of adult T-cell leukaemia (ATL). Subsequently this virus was associated with a myelopathy endemic in the Caribbean56 and Japan,' a condition now called tropical spastic paraparesis (TSP) or HTLV-1 myelopathy (HAM). TSP is an inflammatory demyelinating and degenerative myelopathy predominantly affecting the thoracic and lumbar regions causing a progressive paraparesis with sphincter involvement.89 Immune mechanisms probably play an important part in the pathogenesis of this condition.'0
The discovery of the association of HTLV-1 with TSP and the similarities between TSP and the primary progressive form of multiple sclerosis (MS) led to an intensive search for retroviruses in the latter condition. Two groups of workers" 12 claimed that an HTLV-1 like agent was indeed associated with MS and considerable excitement engendered by the observation that using DNA 
Superantigens
For an antigen to be recognised by the immune system a number of obligatory requirements must be fulfilled. First, the antigen has to be presented by an antigen presenting cell (APC) to that set of lymphocytes bearing the CD4 marker. Secondly, the APCs must exhibit an appropriate major histocompatibility complex (MHC) group so that the peptide can neatly fit in the groove of the complex for presentation to the lymphocyte. Thirdly, the T-cell receptor (TCR) of the lymphocyte must be of the appropriate type. The major TCR has an alpha and a beta chain, both of which have a constant and variable region; within the latter are the hypervariable and junctional zones that are important for recognition of a particular peptide. The result of this complex arrangement is that for recognition of a peptide there is both MHC and TCR restriction culminating in an exquisitely specific immune response.
This system, however, is not the only one available for the initiation of an immune response. There is another, much less specific mechanism, namely: the superantigen system. Certain antigens such as Staphylococcal enterotoxin combine with the beta chain of the TCR on its lateral surface rather than being presented in combination with a particular MHC group to the whole TCR. This combination, which is thus largely independent of the MHC group, can stimulate the lymphocyte. It has long been recognised that there are minor lymphocyte stimulating (Mls) antigens that result in a relatively non-specific stimulation of T-cells; thus a mixed lymphocyte reaction can occur between cells of compatible MHC groups because of these naturally occurring antigens. ' basis28 and there may be a paucity of other immune diseases in patients, particularly rheumatoid arthritis. These differences are readily explicable in terms of MHC and TCR restriction provided the restriction extends to the effector arm of the immune response. To activate a clone of cells against a peptide it is necessary for the peptide to nest within the MHC groove; in the absence of this association between peptide and MHC molecule an immune response will not occur or be limited. It is quite possible that the appropriate antigens for certain diseases are of a configuration that fits a limited number of MHC groups some of which will be satisfactory for MBP and others will be quite incompatible, with gradations in between. A similar argument also applies to the adequacy of the TCR in the recognition of a particular peptide. That this hypothesis is not fanciful is indicated by the occurrence of multisystem disorders in known retroviral diseases of humans and animals. For example HTLV-1 myelopathy is commonly associated with myositis and a pneumonitis in humans, while ovine visna (myelopathy) is accompanied by a pneumonitis (maedi) and caprine encephalitis virus also causes an arthritis. All these groupings could be explained by MHC or TCR restriction.
Finally, the retroviral hypothesis of MS could explain some of the epidemiological features of the disease. First, the geographical restriction of MS is explicable in terms of the putative retrovirus being found only in temperate zones. Second, it would explain some features of migration studies where there is evidence of a prolonged incubation period a feature typical of retroviral infection. Relevant to both these points Dean has shown that migration to South Africa, an area of low incidence, from Northern Europe (high incidence area) before sexual maturity protects the patient from MS. 
